Dae Gon Ha, PhD

Contact Us

Dae Gon Ha, PhD, is a Vice President and BTIG Biotechnology Analyst. Prior to BTIG, Dr. Ha spent five years as an Equity Research Associate and Analyst at SVB Leerink researching biotechnology companies with a focus on rare diseases. Previously, he was a postdoctoral fellow at the Department of Microbiology at Harvard Medical School. Dr. Ha earned a PhD in microbiology and immunology from the Geisel School of Medicine at Dartmouth and a BA with honors in biology from Grinnell College.



Coverage Area

Company Ticker
Apellis Pharmaceuticals APLS
Aurinia Pharmaceuticals AUPH
BioCryst Pharmaceuticals BCRX
ChemoCentryx CCXI
Corbus Pharmaceuticals CRBP
Amicus Therapeutics FOLD
Fulcrum Therapeutics FULC
InflaRx N.V. IFRX
Reata Pharmaceuticals RETA
Retrophin RTRX